$Vir Biote_老虎社区_美港股上老虎

牛唐
2019-10-13

$Vir Biotechnology, Inc.(VIR)$ipo首日暴跌三成，公司主要技术路线为siRNA，适应症为乙型肝炎病毒、甲型流感、艾滋病毒和肺结核，研发进度最快的是ALN-HBV02在乙肝方面的临床试验，已经进入二期，公司与阿斯利康、ALNY、大冢制药等药厂均有合作。公司股东有比尔盖茨&梅琳达基金、软银愿景基金等知名机构。
公司最近的催化剂是在明年上半年公布的乙肝二期数据，建议大家以观望为主
$阿里巴巴(BABA)$$微软(MSFT)$$百济神州(BGNE)$$再鼎医药(ZLAB)$

# 记一个想法

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

玛雅1988
·2019-11-13
[财迷]
回复
点赞
举报
想飞的鱼026
·2019-10-14
谢谢分享
回复
点赞
举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":931547763,"tweetId":"931547763","gmtCreate":1570957630552,"gmtModify":1704721539232,"author":{"id":3452938437060827,"authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[{"themeId":"5aec4c1e42784892a87b4ea0801f57c2","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"记一个想法","type":3,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/discussion&rndata={\"themeId\":5aec4c1e42784892a87b4ea0801f57c2}&rnconfig={\"headerBarHidden\": true}","description":"分享推动思考，思考完善行动","image":"https://static.tigerbbs.com/a1ddb776c9a86cee800ae56ad8ea265e"}],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body> <a href=\"https://laohu8.com/S/VIR\">$Vir Biotechnology, Inc.(VIR)$</a>ipo首日暴跌三成，公司主要技术路线为siRNA，适应症为乙型肝炎病毒、甲型流感、艾滋病毒和肺结核，研发进度最快的是ALN-HBV02在乙肝方面的临床试验，已经进入二期，公司与阿斯利康、ALNY、大冢制药等药厂均有合作。公司股东有比尔盖茨&amp;梅琳达基金、软银愿景基金等知名机构。 公司最近的催化剂是在明年上半年公布的乙肝二期数据，建议大家以观望为主&nbsp; <a href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a><a href=\"https://laohu8.com/S/BGNE\">$百济神州(BGNE)$</a><a href=\"https://laohu8.com/S/ZLAB\">$再鼎医药(ZLAB)$</a> </body></html>","htmlText":"<html><head></head><body> <a href=\"https://laohu8.com/S/VIR\">$Vir Biotechnology, Inc.(VIR)$</a>ipo首日暴跌三成，公司主要技术路线为siRNA，适应症为乙型肝炎病毒、甲型流感、艾滋病毒和肺结核，研发进度最快的是ALN-HBV02在乙肝方面的临床试验，已经进入二期，公司与阿斯利康、ALNY、大冢制药等药厂均有合作。公司股东有比尔盖茨&amp;梅琳达基金、软银愿景基金等知名机构。 公司最近的催化剂是在明年上半年公布的乙肝二期数据，建议大家以观望为主&nbsp; <a href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a><a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$</a><a href=\"https://laohu8.com/S/BGNE\">$百济神州(BGNE)$</a><a href=\"https://laohu8.com/S/ZLAB\">$再鼎医药(ZLAB)$</a> </body></html>","text":"$Vir Biotechnology, Inc.(VIR)$ipo首日暴跌三成，公司主要技术路线为siRNA，适应症为乙型肝炎病毒、甲型流感、艾滋病毒和肺结核，研发进度最快的是ALN-HBV02在乙肝方面的临床试验，已经进入二期，公司与阿斯利康、ALNY、大冢制药等药厂均有合作。公司股东有比尔盖茨&梅琳达基金、软银愿景基金等知名机构。 公司最近的催化剂是在明年上半年公布的乙肝二期数据，建议大家以观望为主 $阿里巴巴(BABA)$$微软(MSFT)$$百济神州(BGNE)$$再鼎医药(ZLAB)$","highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/931547763","repostId":0,"isVote":1,"tweetType":1,"viewCount":5050,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ZLAB","BABA","BGNE","MSFT","VIR"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":397,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":1948534,"gmtCreate":1573599284295,"gmtModify":1573599284295,"authorId":3469005394844389,"author":{"id":3469005394844389,"authorId":3469005394844389,"name":"玛雅1988","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":931547763,"type":1,"supId":0,"prevId":0,"content":"[财迷]","text":"[财迷]","html":"[财迷]","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":1886973,"gmtCreate":1571038923998,"gmtModify":1571038923998,"authorId":3479274769258349,"author":{"id":3479274769258349,"authorId":3479274769258349,"name":"想飞的鱼026","avatar":"https://static.laohu8.com/picture97","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":931547763,"type":1,"supId":0,"prevId":0,"content":"谢谢分享","text":"谢谢分享","html":"谢谢分享","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

评论（2）

热议股票